Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein James K. Liao Clinical Trials Report 14 June 2009 Pages: 243 - 244
Genetically elevated C-reactive protein and ischemic vascular disease James K. Liao Clinical Trials Report 14 June 2009 Pages: 245 - 245
Moving toward new statin guidelines in a post-JUPITER world: Principles to consider Paul M. Ridker OriginalPaper 14 June 2009 Pages: 249 - 256
Diet and lifestyle influences on risk of coronary heart disease Frank B. Hu OriginalPaper 14 June 2009 Pages: 257 - 263
Metabolic syndrome: Perception or reality? David C. W. Lau OriginalPaper 14 June 2009 Pages: 264 - 271
Planning primary prevention of coronary disease Bill Lands OriginalPaper 14 June 2009 Pages: 272 - 280
Efficacy of peroxisome proliferator-activated receptor agonists in diabetes and coronary artery disease Catherine FiƩvetBart Staels OriginalPaper 14 June 2009 Pages: 281 - 288
Circadian rhythm and cardiovascular disease Elizabeth ShawGeoffrey H. Tofler OriginalPaper 14 June 2009 Pages: 289 - 295
Statins and ischemic stroke severity: Cytoprotection Larry B. Goldstein OriginalPaper 14 June 2009 Pages: 296 - 300
Chronic kidney disease and statins: Improving cardiovascular outcomes D. Benson WalkerThanh Jennifer WalkerTerry A. Jacobson OriginalPaper 14 June 2009 Pages: 301 - 308
Statins and their use in preventing carotid disease Henrik Sillesen OriginalPaper 14 June 2009 Pages: 309 - 314
Review of the SPARCL trial and its subanalyses Kenneth M. Welch ReviewPaper 14 June 2009 Pages: 315 - 321